Intended Audience:
This program is intended for emergency physicians, as well as physician specialists who manage patients in the coronary care unit, and cardiac catheterization laboratory.
Grantor Support:
Supported by an independent educational grant from The Medicines Company, Inc.
Registration:
Enrollment for this webcast is complimentary, and clinicians are invited to attend this CME-certified symposium and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.
Accreditation Statement for Jointly-Sponsored Programs:
This activity has been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical Education
through the joint sponsorship of The University of Massachusetts Medical School
and CMEducation Resources, LLC. The University of Massachusetts Medical School
is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement:
The University of Massachusetts Medical School designates this educational activity
for a maximum of 3 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit
commensurate with the extent of their participation in the activity.
Policy on Faculty and Provider Disclosure:
It is the policy of the University of Massachusetts Medical School to ensure fair
balance, independence, objectivity and scientific rigor in all activities. All
faculty participating in CME activities sponsored by the University of Massachusetts
Medical School are required to present evidence-based data, identify and reference
off-label product use and disclose all relevant financial relationships with those
supporting the activity or others whose products or services are discussed. Faculty
disclosure will be provided in the activity materials.
Faculty Disclosures:
Charles V. Pollack, Jr., MA, MD, FACEP, FAAEM
Consultant: TMC, Sanofi-Aventis, BMS, Schering-Plough
Speaker’s Bureau: Sanofi-Aventis, BMS, Schering-Plough
James Hoekstra, MD
Grant/Research Support: Schering Plough, Biosite
Speaker’s Bureau: Sanofi-Aventis, BMS, Schering Plough, and Medicines Company
Judd F. Hollander, MD
Grant/Research Support: Sanofi-aventis
Consultant: Sanofi-Aventis, Medicines Company, PDL, Genetech
Speaker’s Bureau: Sanofi-Aventis, Medicine Company, PDL, Genetech
Educational Objectives:
-
Emergency specialists, cardiac specialists, and other physicians will learn to risk stratify patients with ischemic coronary syndromes and identify optimal antithrombotic therapy for those undergoing PCI
-
Emergency specialists, cardiac specialists, and other physicians will learn to coordinate transitioning antithrombotic care from the emergency department to the cath lab.
-
Emergency specialists, cardiac specialists, and other physicians will learn evidence-based approaches to reducing bleeding complications and risk of transfusion in patients undergoing PCI
-
Emergency specialists, cardiac specialists, and other physicians will learn how to select antithrombotic agents to balance reduction of ischemic complications with reduction in bleeding complications
-
Emergency specialists, cardiac specialists, and other physicians will learn how landmark trials and analyses focusing on ACS can assist in guiding antithrombotic therapy
Distinguished Program Faculty and Panel Members
Charles V.
Pollack, Jr.
, MA, MD, FACEP, FAAEM
(Program Chairman)
Consultant, Department of Emergency Medicine
Pennsylvania Hospital
Associate Professor of Emergency Medicine
University of Pennsylvania School of Medicine
Philadelphia, PA
James
Hoekstra
, MD
Professor and Chairman
Department of Emergency Medicine
Wake Forest Universty Health Sciences
Winston-Salem, NC
Judd F.
Hollander
, MD
Professor and Clinical Research Director
Department of Emergency Medicine
University of Pennsylvania
Philadelphia, PA
Copyright (c) 2006 All rights reserved including
